Upgrade to SI Premium - Free Trial

Gilead Sciences (GILD) PT Raised to $160 at BMO Capital

February 11, 2026 5:08 AM
BMO Capital analyst Evan David Seigerman raised the price target on Gilead Sciences (NASDAQ: GILD) to $160.00 (from $150.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles